Urolithiasis Clinical Trial
Official title:
Metabolic Evaluation of Urolithiasis: Comparison of 24-hour Collecting Urine Prior and After Stone Removal - a Prospective Study
The metabolic evaluation is crucial for determining possible underlying diseases causing stone growth and to consider the lifestyle changes or medical prophylaxis needed to prevent or at least reduce stone recurrence. 24-hour urine collection is the main part of the metabolic evaluation. The time point is suggested between 3 weeks and 3 month after stone removal, but so far there are no studies comparing 24-hour urine prior and after stone removal. In this study, investigators would like to analyze parameters in the 24-hour urine prior and after complete stone removal to see whether metabolic status can be evaluated no matter stone free or not.
Background As the metabolic evaluation is an essential part of diagnostic and recurrence
prevention of urolithiasis, the current EAU Guidelines, as well as the German S2k guidelines
therefore suggest 24-hour urine collection, done twice. This evaluation is crucial for
determining possible underlying diseases causing stone growth and to consider the lifestyle
changes or medical prophylaxis needed to prevent or at least reduce stone recurrence.
The time point is suggested between 3 weeks and 3 month after stone removal, but so far there
are no studies comparing 24-hour urine prior and after stone removal. This could simplify the
diagnostic and make this essential information available for more patients suffering from
urolithiasis.
Hypothesis
Null hypothesis: The analyzed parameters in the 24-hour urine prior and after complete stone
removal differ from each other Alternative hypothesis: The analyzed parameters in the 24-hour
urine prior and after complete stone removal do not differ from each other Primary endpoint:
The difference of the analyzed parameters prior and after complete stone removal
Parameters to be collected
1. 24h urine composition prior and after stone removal: pH value, spec. weight, creatinine,
calcium, oxalate, uric acid, citrate, magnesium, phosphate, ammonium, cysteine, sodium,
potassium.
2. Secondary: Age, sex, body mass index, stone composition analyzed by infrared
spectroscopy, urine culture, comorbidities (diabetes mellitus, hypertension, …), degree
of hydronephrosis, serum electrolytes, blood urea nitrogen, serum creatinine, first
manifestation or recurrent disease
Methods
- After assessing inclusion and exclusion criteria, all eligible patients administered for
active stone removal are included in this study.
- Prior to surgery, a 24-hour urine collection need to be performed (not longer than 2
month).
- Post-operatively stone free status is assessed by NCCT, in ureterolithiasis only if
stone free status is uncertain.
- 4 weeks after proven stone free status the post surgical 24h urine collection is
performed.
- If a ureter stent was placed, the 24-hour urine collection is performed 4 weeks after
stent removal.
- All 24-hour collection are performed as outpatients. Patients will be asked to drink and
eat normally when they do their urine collection. Urinary volume is measured as a marker
of liquid consumption, sodium as a marker of salt intake.
Sample size As no available data to show the difference of urine composition prior or after
surgery, the study will enroll 100 participants first to get preliminary data. Then the final
sample size will be determined by the preliminary data.
Statistical Analysis: Comparisons of the urine compositions before and after stone removal
will be performed using the Student's t-test for continuous variables and chi-squared for
categorical variables.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |